Scientists Identify Novel Genes Linked to Motor Neuron Disease
This study reveals three new risk genes for ALS, and one of these – C21orf2 – increases an individual’s risk of developing the disease by 65 percent. These results could aid the development of personalized treatments for people with ALS by using gene therapy – an approach which involves replacing faulty genes or adding new ones. One in every 400 people will be diagnosed with ALS at some point in their lives, yet its causes are largely unknown and effective treatments are therefore lacking. To read more, click here.
GOODMAN Oral Board Preparation Course Tumor
Nov. 1-3, 2017; Glendale, Ariz.
2017 Managing Coding and Reimbursement Challenges
Aug. 17-19, 2017; Chicago
2017 From Cranial to Spine: An Overview of Neurosurgical Topics for the Advanced Practice Provider
Aug. 30-Sept. 2, 2017; Chicago
Mayo Clinic Neuroscience and Oncology Innovation Summit 2017
Sept. 7-9, 2017; Orlando, Fla.
63rd Annual Meeting of the Western Neurological Society
Sept. 8-11, 2017; Banff, Alberta, Canada